They examine its role in cell migration, cytoskeletal organization, and extracellular matrix remodeling
From Rat Studies to Human Extrapolation From rat studies, the remarkably consistent effective dose range of 0.0045 mg/lb to 0.0000045 mg/lb intraperitoneally (a 1000-fold range showing similar efficacy) worked across depression, anxiety, Parkinsons, stroke, schizophrenia, and seizure models
It described a planned safety and pharmacokinetic study of BPC-157 in healthy volunteers
ID, AK, HZ, and MK: validation
BPC-157 and similar "performance peptides" marketed for muscle recovery lack human validation despite extensive preclinical data
Neurological Applications Both peptides have demonstrated some therapeutic potential in neurological applications, though this represents a less extensively studied area